Atom Investors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.96M Sell
31,468
-24,170
-43% -$1.53M 0.11% 204
2026
Q2
$3.21M Sell
55,638
-68,887
-55% -$3.96M 0.29% 70
2026
Q1
$7.55M Buy
+124,525
New +$7.26M 0.54% 22
2025
Q4
– Sell
-101,509
Closed -$4.58M – 599
2025
Q3
$4.58M Buy
101,509
+49,292
+94% +$2.3M 0.35% 85
2025
Q2
$2.42M Buy
+52,217
New +$2.56M 0.21% 135
2024
Q3
– Sell
-42,400
Closed -$1.76M – 477
2024
Q2
$1.76M Buy
42,400
+36,849
+664% +$1.65M 0.18% 174
2024
Q1
$301K Sell
5,551
-18,370
-77% -$936K 0.04% 409
2023
Q4
$1.23M Buy
+23,921
New +$1.26M 0.22% 158
2020
Q4
– Sell
-5,390
Closed -$331K – 390
2020
Q3
$325K Buy
+5,390
New +$324K 0.03% 281

Other funds holding BMY

Atom Investors's BMY Position: Q3 2026 in Review

Atom Investors reduced its Bristol-Myers Squibb (BMY) stake by 43% in Q3 2026, selling an estimated $1.53M and leaving 31,468 shares worth $1.96M. The position accounts for 0.11% of the portfolio, ranked #204.

Atom Investors first reported a position in BMY in Q3 2020 and has held it in 9 quarters since. The position peaked at $7.55M in Q1 2026. 2,569 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Atom Investors held 31,468 shares of Bristol-Myers Squibb worth $1.96M as of Q3 2026.
  • Atom Investors sold 24,170 Bristol-Myers Squibb shares in Q3 2026, an estimated $1.53M.
  • Bristol-Myers Squibb made up 0.11% of Atom Investors's portfolio in Q3 2026, its #204 holding.
  • Atom Investors first reported a position in Bristol-Myers Squibb in Q3 2020 and has held it in 9 quarters since.
  • Atom Investors's Bristol-Myers Squibb position peaked at $7.55M in Q1 2026.
  • 2,569 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Atom Investors's 13F filing for Q3 2026, filed 16 Nov 2026.